The Heart -- Orlando, FL - The addition of niacin to statin therapy in secondary-prevention patients resulted in a significant improvement in LDL- and HDL-cholesterol levels but failed to significantly alter atherosclerotic disease progression as measured by MRI, compared with statin therapy alone.
